# Lacosamide IV and EEG/EKG (LIVE) Study

> **NCT01724918** · PHASE2 · TERMINATED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 72 (actual)

## Conditions studied

- Focal Epilepsy

## Interventions

- **DRUG:** Lacosamide

## Key facts

- **NCT ID:** NCT01724918
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 72 (ACTUAL)
- **Why stopped:** Time limitation for recruitment exceeded. 72 of 90 estimated sample recruited.
- **Last updated:** 2016-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01724918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01724918, "Lacosamide IV and EEG/EKG (LIVE) Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01724918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*